BATRK Q1 2026 Earnings EPS Surpasses Estimates Despite Stock Decline Tango Therapeutics Q1 2026 Earnings Slight EPS Miss as PreRevenue Biotech Focuses on Pipeline Progress ABUS Q1 2026 Earnings EPS Miss and Ongoing Pipeline Development SWBI Q1 2026 Earnings Earnings per Share Beat Estimates Revenue Details Not Provided REZI Q1 2026 Earnings EPS Beats Estimates Stock Gains 4